+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NGLFINE

NGL Fine - Chem Share Price

₹2,908.40 -545.6 (-15.8%)
New 52W High in past week

17 Aug, 2026 3:59 PM (IST)

NGL Fine - Chem live price: ₹2,908.40. It opened at ₹3,490 vs previous close ₹3,454; intraday high/low: ₹3,490/₹2,801. The 50 & 200 DMA stand at ₹3,115.50/₹2,428.00.

NGL Fine - Chem Performance

  • Today's Low
  • ₹2,801
  • Today's High
  • ₹3,490
  • 52 Week Low
  • ₹1,271
  • 52 Week High
  • ₹3,602
  • Open Price₹3,490
  • Previous Close₹3,454
  • Volume61,009
  • 50 DMA₹3,115.50
  • 100 DMA₹2,825.40
  • 200 DMA₹2,428.00

NGL Fine - Chem Chart

Investment Returns

  • Over 1 Month -5.8%
  • Over 3 Month + 23.74%
  • Over 6 Month + 27.04%
  • Over 1 Year + 111.8%

Smart Investing Starts Here Start SIP with NGL Fine - Chem for Steady Growth!

Invest Now

NGL Fine - Chem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.4
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 1,797
  • P/B Ratio
  • 5.5
  • Average True Range
  • 192.7
  • EPS
  • 92.6
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 51.3
  • RSI
  • 34.28
  • MFI
  • 51.07

Latest Stock News Updates

NGL Fine Chem Ltd - 524774 - Announcement under Regulation 30 (LODR)-Investor Presentation

Investors Presentation - Q1FY27

NGL Fine Chem Ltd - 524774 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Financial Results for the quarter ended June 30, 2026.

Q1FY27 Quarterly Result Announced for NGL Fine - Chem Ltd.

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company NGL Fine - Chem announced Q1FY27 results</strong></span></h3> <p><strong _ngcontent-ng-c1940132427="">Consolidated Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Total Income:</strong> For Q1FY27, the company reported Total Income of Rs 14,659.09 lakh, representing a growth of 32.61% YoY from Rs 11,053.89 lakh in Q1FY26. On a QoQ basis, it saw a slight decrease of 3.36% from Rs 15,169.20 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Revenue from Operations:</strong> Revenue stood at Rs 13,916.28 lakh in Q1FY27, an increase of 33.57% YoY compared to Rs 10,418.54 lakh in Q1FY26. This was a decrease of 6.75% QoQ from Rs 14,923.28 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Profit Before Tax (PBT):</strong> The company achieved a PBT of Rs 2,447.68 lakh in Q1FY27, marking a significant growth of 106.74% YoY from Rs 1,183.95 lakh in Q1FY26 and an increase of 37.41% QoQ from Rs 1,781.25 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Net Profit (PAT):</strong> Net Profit for Q1FY27 was Rs 1,839.72 lakh, up by 99.09% YoY from Rs 924.06 lakh in Q1FY26. It also increased by 36.42% QoQ from Rs 1,348.56 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Total Comprehensive Income:</strong> This stood at Rs 1,803.64 lakh for Q1FY27, compared to Rs 899.59 lakh in Q1FY26 (up 100.50% YoY) and Rs 1,339.23 lakh in Q4FY26 (up 34.68% QoQ).</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Earnings Per Share (EPS):</strong> Basic and Diluted EPS rose to Rs 29.78 in Q1FY27 from Rs 14.96 in Q1FY26 and Rs 21.83 in Q4FY26.</li> </ul> <p><strong _ngcontent-ng-c1940132427="">Standalone Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Total Income:</strong> Standalone Total Income for Q1FY27 was Rs 14,406.99 lakh, a growth of 34.13% YoY from Rs 10,741.15 lakh in Q1FY26. QoQ, it decreased by 2.16% from Rs 14,725.73 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Revenue from Operations:</strong> Standalone revenue reached Rs 13,671.32 lakh in Q1FY27, up 35.55% YoY from Rs 10,085.81 lakh in Q1FY26. It saw a 5.55% decrease QoQ from Rs 14,474.55 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Profit Before Tax (PBT):</strong> PBT for Q1FY27 was Rs 2,174.51 lakh, showing a sharp increase of 123.84% YoY from Rs 971.47 lakh in Q1FY26 and 46.18% QoQ from Rs 1,487.53 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Net Profit (PAT):</strong> PAT for Q1FY27 was Rs 1,645.13 lakh, an increase of 115.22% YoY from Rs 764.41 lakh in Q1FY26 and a 44.89% increase QoQ from Rs 1,135.42 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Earnings Per Share (EPS):</strong> Standalone EPS improved to Rs 26.63 in Q1FY27 compared to Rs 12.37 in Q1FY26 and Rs 18.38 in Q4FY26.</li> </ul> <p><strong _ngcontent-ng-c1940132427="">Business Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Segment Wise Performance:</strong> The company is primarily engaged in the manufacture of pharmaceuticals. Management views this as a single business segment in accordance with IND-AS 108 "Operating Segment."</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Subsidiary Operations:</strong> The consolidated results include the performance of NGL Fine-Chem Limited along with its 100% wholly-owned subsidiary, Macrotech Polychem Private Limited.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Other Income:</strong> The company recorded Other Income of Rs 742.81 lakh on a consolidated basis in Q1FY27, a significant increase from Rs 245.92 lakh in Q4FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5784828/" target="_blank">Result PDF</a></p>

NGL Fine - Chem Financials

NGL Fine - Chem Technicals

EMA & SMA

Current Price
₹2,908.40
-545.6 (-15.8%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹3,286.00
  • 50 Day
  • ₹3,115.50
  • 100 Day
  • ₹2,825.40
  • 200 Day
  • ₹2,428.00

Resistance and Support

3066.5 Pivot Speed
  • R3 4,020.80
  • R2 3,755.40
  • R1 3,331.90
  • S1 2,643.00
  • S2 2,377.60
  • S3 1,954.10

NGL Fine - Chem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-12 Quarterly Results
2026-05-21 Audited Results
2026-02-03 Quarterly Results
2025-11-12 Quarterly Results
2025-08-01 Quarterly Results
Date Purpose Remarks
2026-08-18 FINAL Rs.1.75 per share(35%)Final Dividend
2025-08-12 FINAL Rs.1.75 per share(35%)Final Dividend
2024-08-16 FINAL Rs.1.75 per share(35%)Final Dividend
2023-08-18 FINAL Rs.1.75 per share(35%)Final Dividend
2022-06-23 FINAL Rs.1.75 per share(35%)Final Dividend
View NGL Fine - Chem Dividend History Arrow

NGL Fine - Chem Shareholding Pattern

72.49%
27.43%
0.05%
0.02%

About NGL Fine - Chem

NGL Fine-Chem operates at the intersection of pharmaceutical science manufacturing precision and healthcare reliability. Serving both animal and human health markets, the Company manufactures and exports Active Pharmaceutical Ingredients (APIs), advanced intermediates and finished dosage forms, across global markets. Over the last four decades, NGL has evolved from being a strong domestic manufacturer into a globally trusted partner known for process expertise, dependable supply and consistent quality.(Source : 202603 Annual Report Page No:05) View More
  • NSE Symbol
  • NGLFINE
  • BSE Symbol
  • 524774
  • ISIN
  • INE887E01022

Similar Stocks to NGL Fine - Chem

NGL Fine - Chem FAQs

NGL Fine - Chem share price is ₹2,908 As on 18 August, 2026 | 01:36

The Market Cap of NGL Fine - Chem is ₹1796.8 Cr As on 18 August, 2026 | 01:36

The P/E ratio of NGL Fine - Chem is 31.4 As on 18 August, 2026 | 01:36

The PB ratio of NGL Fine - Chem is 5.5 As on 18 August, 2026 | 01:36

The 52 week High & Low of NGL Fine - Chem is ₹3602/₹1271 respectively As on 18 August, 2026 | 01:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23